The 2026 Healthtech Messaging Index
Eko Health
ekohealth.com·scored August 23, 2026
27/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push Eko Health into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered digital stethoscope for heart and lung disease detection, it named:
Buyer we put in the prompt: Clinician (physician, NP, PA) or health system administrator responsible for cardiac and pulmonary diagnostics or clinical operations. Both the buyer and the category were inferred from Eko Health’s homepage alone. The model had no web access.
Eko Health was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "AI-powered digital stethoscope for heart and lung disease detection", and described you accurately: "Eko Health makes FDA-cleared AI-powered digital stethoscopes designed to detect cardiac conditions like atrial fibrillation and murmurs, as well as pulmonary disease, integrating software intelligence with enhanced acoustic hardware for point-of-care use.". Your positioning is landing with the machines.
Overall assessment
Eko Health's biggest strength is its proof density ... the 2x detection stat, 9 FDA clearances, 70+ clinical publications, and a Lancet study give it rare, citation-ready credibility that most medtech homepages lack. The biggest gap is that the page never acknowledges alternatives or competitors, and the dual-audience hero (individual providers vs. enterprise health systems) with split CTAs prevents either buyer from feeling directly called out, weakening conversion clarity.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, alternative approaches, or 'do nothing' framing anywhere on the page.”
The page never acknowledges that buyers could choose a traditional stethoscope, a competitor device, or do nothing ... alternatives are entirely absent.
All 19 signals, scored 0 to 2.
Total 27/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“We've reimagined the stethoscope for modern medicine. With Eko, you can detect even the most subtle signs of heart and lung disease.”
The product category (stethoscope) and benefit (disease detection) are clear in seconds, but 'modern medicine' is vague and there's no explicit ICP or point of view surfaced above the fold.
- 1
02Rebellion / Movement
“Over 60% of heart diseases go undiagnosed.”
There's an implied enemy (missed diagnoses, human limitations like exhaustion and noise), but no named status quo, named industry pattern, or explicit movement being declared ... it reads as problem framing, not rebellion.
- 1
03Owned Language & Category
“We created a modern replacement for the stethoscope, and paired it with clinically proven AI and health system integrations for earlier disease detection.”
Eko doesn't coin or own a category term or named framework; 'AI-enabled stethoscope' and 'earlier disease detection' are descriptive but not ownable terms an LLM would uniquely attribute to Eko.
- 1
04ICP Clarity
“For Providers... For Health Systems... For Life Science”
Three audiences are named but only at the bottom of the page; no role, company size, or stage is specified in the hero, so individual buyers vs. enterprise buyers must scroll far to self-identify.
- 2
05Problem Leadership
“Over 60% of heart diseases go undiagnosed... missing the warning signs of disease can lead to serious complications and outcomes.”
The page explicitly labels a 'The Problem' section with a concrete statistic before pivoting to the solution, leading with buyer pain in clinical language.
- 2
06Solution Clarity
“We created a modern replacement for the stethoscope, and paired it with clinically proven AI and health system integrations for earlier disease detection.”
A visitor can repeat in one sentence what Eko does: AI-enhanced digital stethoscope for earlier heart and lung disease detection.
- 1
07Cost of Inaction
“missing the warning signs of disease can lead to serious complications and outcomes.”
The cost of inaction is gestured at but kept vague ... 'serious complications and outcomes' doesn't name specific stakes like missed diagnoses per year, liability, or patient mortality rates.
- 1
08Promised Land
“detect with precision and treat with confidence”
The promised 'after' state is implied (more accurate exams, better patient care) but never painted as a vivid, specific future scenario the buyer can picture themselves living in.
Trust Signal
4 signals
- 2
09Proof & Evidence
“Providers who use Eko are 2x more likely to detect heart disease... 750,000 devices sold... clinically validated in 70+ publications... 9 FDA clearances.”
Multiple concrete, sourced numbers are present including a cited clinical outcome delta, scale metric, and regulatory proof points.
- 1
10Social Proof
“Albert C., VP and Chief of Digital Patient Experience, Sutter Health... Jagmeet S., Chief of Nephrology, Guthrie”
Testimonials have names and titles, but only first names and last initials are used for most, no company logos are displayed, and there are no named video case studies linked from the homepage hero area.
- 2
11Authority & Credibility
“The Lancet Publishes TRICORDER Study... Eko Health Appoints Dr. Steven Steinhubl as Chief Medical Officer... Fox & Friends: Eko CEO Connor Landgraf”
Third-party authority is demonstrated through a Lancet publication, a named CMO appointment, and media appearances ... these are earned credentials, not claimed ones.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, alternative approaches, or 'do nothing' framing anywhere on the page.”
The page never acknowledges that buyers could choose a traditional stethoscope, a competitor device, or do nothing ... alternatives are entirely absent.
AI Signal
6 signals
- 1
13Customer Focus
“Let Eko help you detect signs of disease with confidence, elevate your day-to-day exams, and provide exceptional patient care.”
The page tilts toward the customer's outcomes in testimonials and feature sections but frequently pivots back to Eko's capabilities and credentials, making it a mixed protagonist story.
- 2
14AI-Parmesan Index
“Leverage FDA-cleared AI to detect murmurs, AFib, and low ejection fraction... clinically validated in 70+ publications... 9 FDA clearances.”
AI claims are specific and mechanistic ... named conditions detected (murmurs, AFib, low EF), FDA clearance status cited, and clinical validation referenced ... not vague 'AI-powered' sprinkle.
- 2
15LLM Quotability
“Providers who use Eko are 2x more likely to detect heart disease. Over 60% of heart diseases go undiagnosed.”
These are clean, declarative, citation-ready sentences with sourced statistics that an LLM could lift verbatim to recommend Eko in a clinical AI context.
- 2
16Copyright Freshness
“Fox & Friends: Eko CEO Connor Landgraf on Bringing AI to the Cardiac Exam... American Medical Association: How to Make the Most of Patients' Wearable Data”
Multiple recent blog and newsroom posts are visible on the homepage with recent image timestamps, indicating active content publication in 2025.
- 2
17Entity Distinctiveness
“9 FDA clearances... TRICORDER Study... CORE 500™... SENSORA®... Providers who use Eko are 2x more likely to detect heart disease.”
Named proprietary products (CORE 500™, SENSORA®), a named clinical study (TRICORDER), 9 FDA clearances, and a specific 2x outcome stat make this unmistakably distinct from generic digital health competitors.
- 2
18AI Recommendation Check
“AI described you as: "Eko Health makes FDA-cleared AI-powered digital stethoscopes designed to detect cardiac conditions like atrial fibrillation and murmurs, as well as pulmonary disease, integrating software intelligence with enhanced acoustic hardware for point-of-care use.”
AI named you when asked who it recommends for "AI-powered digital stethoscope for heart and lung disease detection", and described you accurately: "Eko Health makes FDA-cleared AI-powered digital stethoscopes designed to detect cardiac conditions like atrial fibrillation and murmurs, as well as pulmonary disease, integrating software intelligence with enhanced acoustic hardware for point-of-care use.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“SHOP DEVICES... ENTERPRISE SOLUTIONS... HOW IT WORKS”
There are two CTAs in the hero and additional section CTAs, but no numbered process or clear path is shown, and the dual primary CTAs (Shop vs. Enterprise) split focus rather than guiding one buyer type through a clear next step.
Keep the lead
AI already names Eko Health. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Eko Health the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.